Caris Life Sciences, Inc. (CAI) Earnings Call Transcripts

19 earnings calls from August 2020 to August 5, 2026

NasdaqGS US Health Care Biotechnology

About Caris Life Sciences, Inc.

Caris Life Sciences, Inc. (CAI) is a publicly listed company in the Biotechnology industry, within the Health Care sector. It trades on NasdaqGS and is based in US. EarningsCalls.dev maintains a free, full-text archive of its earnings call transcripts — 19 calls on record spanning August 25, 2020 to August 5, 2026. Every transcript is split into speaker-by-speaker segments with headline metrics, free to read or available through our REST API.

Earnings Call History

EarningsCalls.dev has 19 Caris Life Sciences, Inc. earnings call transcripts on record, spanning August 25, 2020 to August 5, 2026. Based on this history, Caris Life Sciences, Inc. reports semi-annually. The most recent call on file is dated August 5, 2026. The full list is below — each row opens the complete, free-to-read transcript.

Ticker
CAI
Exchange
NasdaqGS
Country
US
Sector
Health Care
Industry
Biotechnology
Calls on record
19
First call
August 25, 2020
Most recent
August 5, 2026
Reporting cadence
semi-annually
Quarter Date
Q2 FY2026 Aug 5, 2026 Read transcript →
Company Conference Presentations Jun 8, 2026 Read transcript →
Company Conference Presentations May 12, 2026 Read transcript →
Q1 FY2026 May 7, 2026 Read transcript →
Q4 FY2025 Feb 26, 2026 Read transcript →
Company Conference Presentations Jan 12, 2026 Read transcript →
Q3 FY2025 Nov 5, 2025 Read transcript →
Q2 FY2025 Aug 12, 2025 Read transcript →
Special Calls Jan 10, 2024 Read transcript →
Special Calls Oct 31, 2023 Read transcript →
Earnings Calls Aug 24, 2023 Read transcript →
Shareholder/Analyst Calls May 4, 2023 Read transcript →
Special Calls Dec 9, 2022 Read transcript →
Special Calls Oct 31, 2022 Read transcript →
Shareholder/Analyst Calls May 5, 2022 Read transcript →
Earnings Calls Mar 24, 2022 Read transcript →
Shareholder/Analyst Calls Nov 30, 2021 Read transcript →
Shareholder/Analyst Calls May 6, 2021 Read transcript →
Shareholder/Analyst Calls Aug 25, 2020 Read transcript →